Download Files:
Products Details
Product Description
– ACT-606559, a new chemical entity with antimalarial activity, is a metabolite of ACT451840. ACT-606559 can be used for the research of malarial[1].
Web ID
– HY-141621
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C47H52N6O3
References
– [1]Bruderer S, et al. First-in-humans study of the safety, tolerability, and pharmacokinetics of ACT-451840, a new chemical entity with antimalarial activity. Antimicrob Agents Chemother. 2015;59(2):935-942.
Molecular Weight
– 748.95
SMILES
– CC(N(C=C1)CCN1C(C=C2)=CC=C2CN(C(/C=C/C3=CC=C(C=C3)C(C)(C)C)=O)C(CC4=CC=CC=C4)C(N5CCN(CC5)CC6=CC=C(C=C6)C#N)=O)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Drug Metabolite;Parasite
Isoform
– Plasmodium
Pathway
– Anti-infection;Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
